Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.33963/KP.a2022.0284DOI Listing

Publication Analysis

Top Keywords

decrease cost
4
cost pacemaker
4
pacemaker infection
4
infection treatment
4
treatment adopting
4
adopting seemingly
4
seemingly costly
4
costly innovation?
4
innovation? budget
4
budget impact
4

Similar Publications

Is high specific surface area essential for anode catalyst supports in proton exchange membrane water electrolysis?

Mater Horiz

September 2025

New Cornerstone Science Laboratory, State Key Laboratory for Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials, and College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China.

Dispersing iridium onto high-specific-surface-area supports is a widely adopted strategy to maximize iridium utilization in anode catalysts of proton exchange membrane water electrolysis (PEMWE). However, here we demonstrate that the overall cell performance, including initial efficiency and long-term stability, does not benefit from the typical high specific surface area of catalyst supports. The conventional understanding that high iridium utilization on high-specific-surface-area supports increases activity holds only in aqueous electrolytes, while under the typical working conditions of PEMWE, the mass transport within the anode catalyst layers plays a more significant role in the overall performance.

View Article and Find Full Text PDF

Cooperation involves an individual's choice that benefits both themself and others -in contrast to selfishness, which benefits the individual only-and has been suggested to be more likely when the benefit to others, discounted as a function of their social distance (i.e., social discounting), exceeds the undiscounted cost to the cooperator.

View Article and Find Full Text PDF

Background: Respiratory syncytial virus (RSV) is recognized as the primary cause of hospitalizations among children with lower respiratory tract infections in developed countries, placing a significant burden on both patients and healthcare systems. The efficacy, safety, and immunogenicity of maternal vaccination with the novel RSVpreF vaccine have been evaluated in a Phase III clinical trial, showing a decreased risk of severe infection in infants. Our study assesses the cost-effectiveness of the RSVpreF vaccine and seasonal variation of costs in a Norwegian setting.

View Article and Find Full Text PDF

Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from Multi-Stakeholder Interviews.

Ther Innov Regul Sci

September 2025

Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

Introduction: During the COVID-19 pandemic, regulatory and market access actions were taken to expedite the market entry of COVID-19 medicines. This study aims to (i) capture multi-stakeholder views on these actions, and (ii) provide recommendations for future-proofing routine and health-emergency frameworks.

Methods: Semi-structured interviews were conducted with policy makers/advisors (i.

View Article and Find Full Text PDF